CRP and cancer: OC has poor prognosis; multi-modal screening using carbohydrate antigen (CA)125 values and transvaginal ultrasound have been widely used for predicting OC risk.[4] Several studies have illustrated the role of inflammation in promoting ovarian tumorigenesis and cancer progression, and the involvement of pro-inflammatory cytokines in the pathogenesis of OC.[5–9] C-reactive protein (CRP), an acute-phase protein, is an indicator of infectious or inflammatory conditions and considered as a prognostic factor in different types of cancer.[10,11]